Early RA detection and appropriate treatment improves patient outcomes.
RA is a disease that, if left untreated, results in joint destruction and severe disability. One in three patients are missed by current blood tests. JOINTstat® improves early detection, which together with prompt treatment, can drastically improve a patient’s joint damage outcome and quality of life.
Early & Accurate Detection
JOINTstat® measures 14-3-3η, a joint damage protein that helps identify patients with RA for prompt referral & treatment.
Involved in the Disease Process
The protein that JOINTstat® measures, 14-3-3η, is directly involved in the joint damage process and is associated with prognosis.
JOINTstat™ Test Results Change
With RA treatment and over the disease course, JOINTstat® test results can be tracked alongside clinical assessments.